With over 25 years of experience from its founders, Fast Pharma entered the pharmaceutical market in 2016, aiming to offer value-added solutions by providing products tailored to patients’ needs.
Siklos® it is indicated for the prevention of recurrent painful vaso-occlusive crises, including acute chest syndrome, in adults, adolescents and children over 2 years of age suffering from symptomatic sickle cell syndrome.
*Fast Pharma SAS, representative of Theravia in Colombia
Megestrol acetate
Megestrol Acetate is a progestogen (hormonal treatment), indicated for patients diagnosed with breast cancer, endometrial cancer and anorexia cachexia syndrome.
Named Patient Program Medications (NPP)
An NPP medication is an indispensable and irreplaceable medication to safeguard the life or alleviate the suffering of a patient or a group of patients and that due to conditions of low profitability in its commercialization, it is not available in the country or the quantities are not enough
At Fast Pharma we support the patient, doctors and clients to carry out the necessary procedures for the required medication and thus facilitate access to treatment.
Medications for rare diseases and low prevalence diseases
They are medications for the treatment of rare diseases (RD) or infrequent diseases; that is, they have a low prevalence in the population. To be considered as rare, each specific disease can only affect a limited number of people. Specifically, when it affects less than 5 in 10,000 inhabitants.
However, infrequent pathologies affect a large number of people, since according to the World Health Organization (WHO), there are about 7,000 rare diseases that affect 7% of the world’s population.
At Fast Pharma we are committed to attracting alternatives that positively impact the lives of patients.
Medications for neglected and highly complex diseases
In Colombia, complex diseases lack clarity within the current social security health system, due to their low prevalence, difficult diagnosis, poor treatment, high price of medicines (for which they are considered high cost medicines), and of great economic impact for the health system.
Thinking of improving the quality of life of patients, at Fast Pharma we work through our national and international partners to meet the needs of the market.
Out of stock medications
A drug will be considered supply-problems if it affects a high percentage of the sample pharmacies for 3 or more days of the week or if a large majority of them are affected during a single day.
The criteria established are only an initial starting point whose objective is to simplify and obtain an approximation in the search for medicines in a situation of supply, any other starting point or criterion may be valid.
Fast Pharma knows the processes, advances regulatory procedures and guarantees the logistics operation to facilitate the availability of medications.
Our National and International Alliances allow us to supply the needs of patients, medical staff and institutions with products with high quality standards.